Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis

(2012) Tallal Younis et al.   SUPPORTIVE CARE IN CANCER

5167 POSTER A Multicenter Randomized Phase II Study of KRN125 (Pegfilgrastim) to Determine the Optimal Dosage in Japanese Breast Cancer Patients Receiving TAC Treatment

(2011) N. Masuda et al.   EUROPEAN JOURNAL OF CANCER

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer

(2011) Hyo Sook Han et al.   EUROPEAN JOURNAL OF CANCER

Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—a retrospective analysis

(2010) T. Vandenberg et al.   Current Oncology

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

(2010) M.S. Aapro et al.   EUROPEAN JOURNAL OF CANCER

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy

(2010) Alexandre Chan et al.   SUPPORTIVE CARE IN CANCER

Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients

(2009) D. Takabatake et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

High Rate of Febrile Neutropenia in Patients With Operable Breast Cancer Receiving Docetaxel and Cyclophosphamide

(2009) Derrick Soong et al.   JOURNAL OF CLINICAL ONCOLOGY

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics

(2009) David R. Gandara et al.   JOURNAL OF CLINICAL ONCOLOGY